PK/PD and Bioanalytical Considerations for ADCs

• In: Antibody drug conjugates: Where have we come from? Future opportunities on Wednesday, 13 September 2017, -
• At: Seoul (South Korea) (2017)
• Type: Presentation
• By: MAGER, Don
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login